Neuropeptide system regulation of prefrontal cortex circuitry: implications for neuropsychiatric disorders

SM Casello, RJ Flores, HE Yarur, H Wang… - Frontiers in Neural …, 2022 - frontiersin.org
Neuropeptides, a diverse class of signaling molecules in the nervous system, modulate
various biological effects including membrane excitability, synaptic transmission and …

Multitarget opioid ligands in pain relief: New players in an old game

R Turnaturi, G Aricò, G Ronsisvalle, C Parenti… - European Journal of …, 2016 - Elsevier
Still nowadays pain is one of the most common disabling conditions and yet it remains too
often unsolved. Analgesic opioid drugs, and mainly MOR agonists such as morphine, are …

Endomorphin analog analgesics with reduced abuse liability, respiratory depression, motor impairment, tolerance, and glial activation relative to morphine

JE Zadina, MR Nilges, J Morgenweck, X Zhang… - …, 2016 - Elsevier
Opioids acting at the mu opioid receptor (MOR) are the most effective analgesics, however
adverse side effects severely limit their use. Of particular importance, abuse liability results …

Selective κ receptor partial agonist HS666 produces potent antinociception without inducing aversion after icv administration in mice

M Spetea, SO Eans, ML Ganno… - British Journal of …, 2017 - Wiley Online Library
Background and purpose The κ receptor has a central role in modulating neurotransmission
in central and peripheral neuronal circuits that subserve pain and other behavioural …

Analgesic opioid ligand discovery based on nonmorphinan scaffolds derived from natural sources

MT Smith, D Kong, A Kuo, MZ Imam… - Journal of Medicinal …, 2022 - ACS Publications
Strong opioid analgesics, including morphine, are the mainstays for treating moderate to
severe acute pain and alleviating chronic cancer pain. However, opioid-related adverse …

μ Opioid receptor: novel antagonists and structural modeling

T Kaserer, A Lantero, H Schmidhammer, M Spetea… - Scientific reports, 2016 - nature.com
The μ opioid receptor (MOR) is a prominent member of the G protein-coupled receptor family
and the molecular target of morphine and other opioid drugs. Despite the long tradition of …

Pharmacological characterization of dezocine, a potent analgesic acting as a κ partial agonist and μ partial agonist

YH Wang, JR Chai, XJ Xu, RF Ye, GY Zan, GYK Liu… - Scientific reports, 2018 - nature.com
Dezocine is becoming dominated in China market for relieving moderate to severe pain. It is
believed that Dezocine's clinical efficacy and little chance to provoke adverse events during …

Repeated use of morphine induces anxiety by affecting a proinflammatory cytokine signaling pathway in the prefrontal cortex in rats

S Ahmadi, S Mohammadi Talvar, K Masoudi… - Molecular …, 2023 - Springer
We examined the role of toll-like receptors (TLRs) and proinflammatory cytokine signaling
pathways in the prefrontal cortex (PFC) in anxiety-like behaviors after repeated use of …

Identification and characterization of plant-derived alkaloids, corydine and corydaline, as novel mu opioid receptor agonists

T Kaserer, T Steinacher, R Kainhofer, F Erli, S Sturm… - Scientific reports, 2020 - nature.com
Pain remains a key therapeutic area with intensive efforts directed toward finding effective
and safer analgesics in light of the ongoing opioid crisis. Amongst the neurotransmitter …

Development of multifunctional and orally active cyclic peptide agonists of opioid/neuropeptide FF receptors that produce potent, long-lasting, and peripherally …

M Zhang, B Xu, N Li, R Zhang, Q Zhang… - Journal of medicinal …, 2021 - ACS Publications
We previously reported that a multifunctional opioid/neuropeptide FF receptor agonist, DN-9,
achieved peripherally restricted analgesia with reduced side effects. To develop stable and …